advanced infusion solutions lawsuit advanced infusion solutions lawsuit

Advanced Infusion Services | 114 seguidores en LinkedIn. Our inspiration came from the infusion experiences of our close family: Annette's brother and Lucien's father. [21-30534] (SEP) [Entered: 09/15/2021 10:20 AM], APPEARANCE FORM FILED by Attorney Roberta Louise Burns for Appellant Randy Denning in 21-30534. (Entered: 01/28/2021), (#4) ATTORNEY APPEARANCE: Scott R. Knapp appearing on behalf of Blue Cross Blue Shield of Michigan (Knapp, Scott) (Entered: 01/21/2021), (#3) SUMMONS Issued for *Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions* (NAhm) (Entered: 01/12/2021), (#2) STATEMENT of DISCLOSURE of CORPORATE AFFILIATIONS and FINANCIAL INTEREST by Blue Cross Blue Shield of Michigan (Moody, Nolan) (Entered: 01/11/2021), (#1) COMPLAINT filed by Blue Cross Blue Shield of Michigan against Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Finally, one place to get all the court documents we need. The covenant of good faith and fair dealing is implied in every contract. Escamilla v. Blue Cross Blue Shield of Michigan, d/b/a BCBSM, Wilber v. Compcare Health Services Insurance Corp et al, Mills v. Blue Cross Blue Shield Association et al, Nichols v. Blue Cross Blue Shield of Michigan, Michigan Catastrophic Claims Association v. Steadfast Insurance Company, Bradley v. Blue Cross Blue Shield of Michigan, Display Pack, Inc. v. LEL International, Inc. et al, Romano v. Blue Cross Blue Shield of Michigan. [email protected] (Court Reporter/Transcriber: Sheri Ward, www.transcriptorders.com) (Number of Pages: 21) The parties have 21 days to file with the court and Court Reporter/Transcriber a Redaction Request of this transcript. Citations are also linked in the body of the Featured Case. Report any scam, fraud, complaint or review on any type of company, individual, service or product here. Headquarters 18451 Dallas Pkwy Ste 150, Dallas, Texas, 75287, United States Phone Number (601) 988-1700 Website www.aiscaregroup.com Revenue $23M Industry Pharmaceuticals Healthcare AIS Healthcare's Social Media Is this data correct? BCBS and AHS claim AIS misrepresented its billing for home infusion therapy services under the S9328 code. texts to send an aries man Search. Based on the record as it presently . Counterclaim [47] 9. BOND PHARMACY v. ADVANCED HEALTH SYSTEMS, INC. United States District Court, S.D. (LSau) (Entered: 02/18/2021), Docket(#6) STIPULATION by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions (Winsten, I.) A subscription to PACER is required. Redacted Transcript Deadline set for 8/6/2021. The elements of fraud and intentional misrepresentation are identical, and therefore Rule 9(b)'s heightened pleading standard applies to the latter claim. Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions Case Summary On 01/11/2021 Blue Cross Blue Shield of Michigan filed a Contract - Insurance lawsuit against Bond Pharmacy, Inc d/b/a Advanced Infusion Solutions. 3:11 . Plaintiff / Appellant: Randy Denning. Id. (Entered: 04/08/2021), (#17) STIPULATED ORDER Regarding Motions. (Entered: 04/08/2021), Docket(#17) STIPULATED ORDER Regarding Motions. Maness v. K & A Enters. Descubrir Personas Learning Empleos Unirse ahora . The Agreement's terms and conditions required AIS to submit a claim form that included a charge for home infusion therapy with the corresponding AHS-defined Healthcare Common Procedure Coding System ("HCPCS") procedure codes. Randy DENNING, PlaintiffAppellant, v. BOND PHARMACY, INCORPORATED, doing business as Advanced Infusion Care, doing business as Advanced Infusion Solutions, doing business as AIS Healthcare, DefendantAppellee. [21-30534] (SEP) [Entered: 09/29/2021 03:02 PM], BRIEFING NOTICE ISSUED A/Pet's Brief Due on 10/27/2021 for Appellant Randy Denning. Ridgeland, MS 39157. miles away. [21-30534] (DDL) [Entered: 10/25/2021 04:31 PM], CLERK ORDER granting motion to supplement the record on appeal filed by Appellant Mr. Randy Denning [ # 9692325-2 ] [21-30534] (AGL) [Entered: 10/22/2021 08:19 AM], SUPPLEMENTAL ELECTRONIC RECORD ON APPEAL REQUESTED from District Court for 2:21-CV-774. Doe v. MySpace, Inc.,528 F.3d 413, 418 (5th Cir. Id. In contrast, BCBS and AHS claim they set forth factual descriptions and direct allegations constituting AIS's fraudulent scheme, such that AIS has notice. Action: Case OK to Process. Motion Hearing set for 6/9/2021 02:30 PM before District Judge Denise Page Hood |Zoom Webinar Information: https://www.zoomgov.com/j/1616326086?pwd=dTVZRnlseVBTNFRhNVE0SlhQaEozUT09 Passcode: 999999 Or One tap mobile : US: +16692545252,,1616326086# or +16468287666,,1616326086#| (LSau) (Entered: 04/21/2021), Docket(#19) NOTICE of Appearance by Rian Cierra Dawson on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Request information Receipt No: AMIEDC-8266539 - Fee: $ 402. 27-29, 37, and establishes the remaining elements with particularity, see id. 2:19-CV-12369 | 2019-08-09, U.S. District Courts | Other | R. Civ. AIS Healthcare is proud to announce that its two state-of-the-art 503A compounding pharmacies (Ridgeland, Mississippi; Dallas, Texas) which produce patient-specific prescriptions for targeted drug delivery (TDD), and its five Advanced Infusion Care locations (Valdosta, Georgia; Birmingham, Alabama; Clinton, Mississippi; Panama City, Florida; Dallas, Texas) have received the prestigious URAC . (Knapp, Scott) (Entered: 03/10/2021), (#8) MOTION to Dismiss Plaintiff's Complaint by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. "The breach of good faith is bad faith characterized by some conduct which violates standards of decency, fairness or reasonableness." Learn more about our pharmacies: AIS Healthcare Targeted Drug Delivery Nursing that exceeds expectations may be available from PACER. Limbert v. Miss. AIS argues that BCBS and AHS merely provide a "formulaic recitation of the elements." A party, however, does not breach the covenant when "the party took only those actions which were duly authorized by the contract." United States District Court, S.D. Transcript Order ddl satisfied. Advanced Pain . [Previously dismissed case: No] [Possible companion case(s): None] (Moody, Nolan) (Entered: 01/11/2021). best lebron james cards to invest in; navage canadian tire; is festive ground turkey good. (Werner, Paul) (Entered: 03/11/2021), Docket(#9) MOTION for Default Judgment as to Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions by Blue Cross Blue Shield of Michigan. 2018) (quoting Bus. [57] at 16. This action arises from a contract dispute. Lead Counsel? [21-30534] (SEP) [Entered: 09/15/2021 03:32 PM], APPEARANCE FORM FILED by Attorney Timothy Richardson for Appellant Randy Denning in 21-30534. ORDER KRISTI H. JOHNSON, District Judge. Industry: Health maintenance organization , Drug stores and proprietary stores Printer Friendly View Address: 623 Highland Colony Pkwy Ste 100 Ridgeland, MS, 39157-6077 United States See other locations Phone: Website: www.aiscaregroup.com Employees (this site): Actual ESG industry average: What is D&B's ESG Ranking? (Winsten, I.) [21-30534] (DDL) [Entered: 09/17/2021 02:02 PM], ELECTRONIC RECORD ON APPEAL FILED. ]" TransUnion LLC v. Ramirez, 141 S. Ct. 2190, 2200 (2021) (quoting . Namely, AIS contends they fail to establish the representation, materiality, and intent elements of the claim and to allege the "who, what, when, where, and how." Image Trademark. (LSau) (Entered: 02/18/2021), (#6) STIPULATION by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions (Winsten, I.) Mailing Address: PMB 507 1353 Rd. Id. The site is secure. Id. The .gov means its official.Federal government websites often end in .gov or .mil. The Court has the authority to "declare the rights and other legal relations of any interested party seeking such declaration" pursuant to the Declaratory Judgment Act. I must pay the remaining amount. And by breaching the Agreement, AIS caused BCBS to wrongfully pay the S9328 code. 2008). P. 9(b). Id. Advanced Infusion Solutions is a provider established in Ridgeland, Mississippi operating as a Pharmacy with a focus in home infusion therapy pharmacy . Click on the case name to see the full text of the citing case. ), Blue Cross Blue Shield of Michigan v. Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions, (#25) TRANSCRIPT of Hearing on Defendant's Motion to Dismiss held on 06/23/2021. King & Spalding and Bradley Arant Boult Cummings filed a lawsuit Sunday in Illinois Northern District Court on behalf of Bond Pharmacy d/b/a Advanced Infusion Solutions (AIS). Advanced Infusion Care Clinton 132 Fairmont Street, Suite B Clinton, MS 39056 P: 601.988.1710 I 888.339.2144 F: 229.242.9914 I 844.259.0209 URAC accredited for Specialty Pharmacy Advanced Infusion Care Valdosta 212 Northside Drive Valdosta, GA 31602 P: 229.242.3060 | 800.482.8466 F: 229.242.9914 URAC accredited for Specialty Pharmacy 14. R. Civ. (Entered: 05/12/2021), Docket(#23) NOTICE OF HEARING BY VIDEO CONFERENCE on #18 MOTION to Dismiss Plaintiff's Amended Complaint. Id. 19 Guaynabo, PR 00966 Phone (787) 783-2245 Fax (787) 523-1178 / (787) 781-8384. (Winsten, I.) 15. Motion Hearing set for 6/23/2021 04:00 PM before District Judge Denise Page Hood |Zoom Webinar Information: https://www.zoomgov.com/j/1616326086?pwd=dTVZRnlseVBTNFRhNVE0SlhQaEozUT09 Passcode: 999999 Or One tap mobile : US: +16692545252,,1616326086# or +16468287666,,1616326086#| (LSau) (Entered: 05/11/2021), Docket(#22) NOTICE of Appearance by Kevin M. Cloutier on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Cancellation and Refund Policy, Privacy Policy, and Because the Counterclaim provides enough particularity to provide AIS with notice, the Court denies AIS's motion on this claim. Wisconsin Spine and Pain SC wispineandpain.com 920-204-6758 Locations in Waukesha, West Bend, Sheboygan and Green Bay. Plaintiff requests summons issued. [21-30534] (SEP) [Entered: 09/24/2021 08:54 AM], TRANSCRIPT ORDER received from Appellant Mr. Randy Denning advising transcript unnecessary as it is already filed. AIS is a specialty pharmacy that provides home infusion therapy, which infuses patients' pain medications into the intrathecal space surrounding their spinal cord through surgically implanted pumps. Advanced Infusion Care Our divisions Setting new quality standards in our pharmacies At our state-of-the-art pharmacies, we go beyond state and industry standards to produce patient-specific prescriptions of the highest quality and sterility. Advanced Infusion Solutions (AIS) Pharmaceutical Manufacturing Ridgeland, Mississippi 51 followers Follow View all 33 employees About us AIS HealthCare the leading provider of advanced sterile,. [21-30534] (Timothy Richardson ) [Entered: 09/14/2021 09:49 AM], APPEARANCE FORM for the court's review. AIS sued BCBS and AHS, asserting breach of contract, breach of implied duty of good faith and fair dealing, unjust enrichment, breach of implied-in-fact contract, and failure to provide benefits under ERISA plans, and seeking declaratory judgment that it is entitled to payment. Ashcroft v. Iqbal,556 U.S. 662, 678 (2009) (citing Bell Atl. Commc'ns, Inc. v. Banks,90 So.3d 1221, 1224 (Miss. This case was filed in U.S. District Courts, Michigan Eastern District Court. Case Number: 21-30534. [21-30534] (SEP) [Entered: 10/21/2021 11:21 AM], SUFFICIENT - UNOPPOSED MOTION to supplement the record on appeal with Reasons in Support of Order granting Motion to Dismiss [9692325-2]. Denning v. Bond Pharmacy, Inc. (2:21-cv-00774), Louisiana Eastern District Court, Filed: 04/16/2021 - PacerMonitor Mobile Federal and Bankruptcy Court PACER Dockets See AIS's Memo. Redaction Request due 7/27/2021. Home; Services; New Patient Center. 1:19-CV-00394 | 2019-05-17, U.S. District Courts | Civil Right | . AIS moves to dismiss BCBS and AHS's counter claims under Rule 12(b)(6). Healthy snacks. Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions, 2:21-cv-10076 Brought to you by the RECAP Initiative and Free Law Project, a non-profit dedicated to creating high quality open legal information. Rule 9(b) requires a party to plead with particularity the circumstances constituting fraud. 815 F.Supp.2d 966 (2011) BOND PHARMACY, INCORPORATED, Doing Business as Advanced Infusion Solutions, Plaintiff, v. ANAZAOHEALTH CORPORATION, Defendant. Bond Pharmacy, Incorporated, doing business as Advanced Infusion Care, doing business as Advanced Infusion Solutions, doing business as AIS Healthcare, SUPPLEMENTAL ELECTRONIC RECORD ON APPEAL FILED. 4:22-CV-12577 | 2022-10-26, U.S. District Courts | Contract | AIS argues that BCBS and AHS identified no provision in the Agreement that requires it to personally fill/refill the pumps or provide ongoing services. Balloon Sleeve Big silhouette Over Shirt/ Lawyers for Pharmaceutical Research and Manufacturers of America and U.S. Health and Human Services Secretary Xavier Becerra on Friday jointly asked U.S . P. 8(d)(2). Provider Organization. Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions Plaintiff: Blue Cross Blue Shield of Michigan: Defendant: Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions: Case Number: 2:2021cv10076: Filed: January 11, 2021: Court: US District Court for the Eastern District of Michigan: Presiding Judge: Id. February 7, 2022. The basis for the action "lies in a promise, which is implied in law, that one will pay to the person entitled thereto [that] which in equity and good conscience is his." R. Civ. The NPI number of this provider is 1336243393 and was assigned on September 2006. The NPI Number for Advanced Infusion Solutions is 1346742376. 28 U.S.C. No. Get billing and insurance guidance At AIS Healthcare, we want to make the billing and reimbursement process as easy as possible for you. (Attachments: #1 Exhibit Exhibit 1) (Knapp, Scott) (Entered: 04/28/2021), Docket(#20) NOTICE OF HEARING BY VIDEO CONFERENCE on #18 MOTION to Dismiss Plaintiff's Amended Complaint. Accepting these allegations as true, BCBS and AHS have plausibly stated both elements for breach of contract. Before the Court is Advanced Infusion Solutions' ("AIS") Motion to Dismiss the Counterclaim filed by Blue Cross & Blue Shield of Mississippi ("BCBS") and Advance Health Systems ("AHS") [56]. 2002). [21-30534] (Timothy Richardson ) [Entered: 09/14/2021 09:46 AM], APPEARANCE FORM FILED by Attorney Paul Anthony Werner III for Appellee Bond Pharmacy, Incorporated in 21-30534 [21-30534] (CB) [Entered: 09/14/2021 08:29 AM], ATTORNEY TRANSCRIPT ORDER form filed by Appellant Mr. Randy Denningfor the Court to process. Ct. App. (LSau) (Entered: 04/06/2021), Docket(#10) NOTICE of Appearance by Paul Anthony Werner, III on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. P. C., New York, NY- 503A Facility, Wingate's Pharmacy and Compounding (see Anderson Holdings Inc.), Nashua, NH- 503A Facility, Wise Pharmacy, (see Joe Wise Pharmacy, Inc.), Littleton, CO- 503A Facility, Woodland Hills Compounding Pharmacy, (see Algunas, Inc.), Woodland Hills, CA- 503A Facility, Wood's Pharmacy, Inc., (dba The Medicine Shoppe), Boones Mill, VA- 503A Facility, Yeung Business Solutions, LLC, (dba Reliant Pharmacy), Southbury, CT- 503A Facility, Zion Clinical Pharmacy, (see Pharmacy Doctors Enterprises), Hallandale Beach, FL- 503A Facility, Zions RX Formulations Services, (see Rx Formulations), Mesa, AZ- 503A Facility, Analytical Research Laboratories, (see ARL Biopharma, Inc.), Oklahoma City, OK, ARL Biopharma, Inc., (dba Analytical Research Laboratories), Oklahoma City, OK, Front Range Laboratories, Inc., Loveland, CO, Medisca Inc., Saint-Laurent, Quebec, Canada, and Plattsburgh, NY, Professional Compounding Centers of America, dba PCCA, Houston, TX, Sichuan Friendly Pharmaceutical Co., Limited, China, Taizhou Xinyou Pharmaceutical & Chemical Co., Limited, Taizhou City, Zhejiang Province, China, An official website of the United States government, : Docket for Advanced Reimbursement Solutions LLC v. Aetna Life Insurance Company, 2:19-cv-05395 Brought to you by the RECAP Initiative and Free Law Project, a non-profit dedicated to creating high quality open legal information. Id. Care, Saint Paul, MN- 503A Facility, HHCS Pharmacy, Inc. (dba Freedom Pharmacy), Orlando, FL- 503A Facility, Hieber's Pharmacy, Pittsburgh, PA- 503A Facility, Hiers Enterprises, LLC, (dba Northwest Compounding Pharmacy), Roseburg, OR- 503A Facility, Highland Pharmacy (see In Your Atmosphere Holdings, LLC), Santa Fe, NM- 503A Facility, Home Care Pharmacy of Palm Coast Inc., Palm Coast FL- 503A Facility, HomeChoice Partners, Inc., (dba Bioscrip Infusion Services), Augusta, GA- 503A Facility, Home Infusions Solutions, Inc., Horsham, PA- 503A Facility, Home Intensive Care Pharmacy, Inc., San Antonio, TX- 503A Facility, HomeRx, LLC, (see WellRx, LLC), Wheaton, IL- 503A Facility, Hopewell Pharmacy and Compounding Center,(see Drugs Are Us, Inc.), Hopewell, NJ- 503A Facility, Hopkinton Drug, Inc., Hopkinton, MA- 503A Facility, Horizon Pharmaceuticals, Inc., Riviera Beach, FL- 503A Facility, Hospira Inc., A Pfizer Company, McPherson, KS- 503A Facility, HRI Pharmacy,(see National Prescription Services), Warrenville, IL- 503A Facility, Humco Holding Group, Inc., Texarkana, TX- 503A Facility, Hunter Holmes McGuire Veterans Admin Medical Center, Richmond, VA- 503A Facility, HV Pharmacy Inc. (dba Hunt Valley PharmaLab), Cockeysville, MD- 503A Facility, Hybrid Pharma LLC, Deerfield Beach, FL- 503B Facility, Ideal Specialty Apothecary Inc., (dba Ideal Pharmacy), Union, NJ - 503A Facility, ImClone Systems, LLC, Branchburg, NJ - 503A Facility, ImprimisRx, LLC, Carlsbad CA- Corporate Headquarters, ImprimisRx CA Inc. (dba ImprimisRx), Irvine CA- 503A Facility - Out of business, Imprimis NJOF, LLC, Ledgewood, NJ- 503B Facility, ImprimisRx NJ, Ledgewood, NJ- 503A Facility, ImprimisRx Pharmacy, LLC, Folcroft, PA- 503A Facility - Out of business, INCELL Corporation, LLC, San Antonio, TX- 503A Facility - De-registered as an Outsourcing Facility, Infupharma, LLC(dba President Pharmacy), Hollywood, FL- 503A Facility, InfuScience Inc., Eagan, MN- 503A Facility, InfuScience a subsidiary of Bioscrip, Mount Pleasant, SC- 503A Facility, InfuScience, Inc., (dba Bioscrip Infusion Services), Chantilly, VA- 503A Facility, Infusion Options, Inc., Brooklyn, NY- 503A Facility - Out of business, Infusion Partners, LLC, Canfield, OH- 503A Facility, Infusion Partners (subsidiary of BioScrip), Sharpsburg, PA- 503A Facility, Infusion System of SW Florida Inc. (dba Myerlee Pharmacy), Fort Myers, FL- 503A Facility, Infusion Treatment Center, dba ITC Compounding, Castle Rock, CO- 503A Facility, Innovative Compounding Pharmacy, Folsom, CA- 503A Facility, Innovation Compounding, Inc. Kennesaw, GA- 503A Facility, Innovative Intrathecal Solutions, Inc. (dba Innovative Compounding Pharmacy), Murrieta, CA- 503A Facility, Innovative Medicine LLC, Long Island City, NY- 503A Facility, Innoveix Pharmaceuticals, Addison, TX- 503A Facility, Insight Pharmacy, Havertown, PA- 503A Facility, Intact Pharmaceuticals, LLC, New Milford, CT- 503B Facility - Out of business, IntegraDose Compounding Services, LLC, Minneapolis, MN- 503B Facility, Integrated Health Concepts Inc. (dba Conversio Health), San Luis Obispo, CA- 503A Facility, Intermountain Medical Center, Murray, UT- 503A Facility, Intrathecal Compounding Specialist, LLC, Scott, LA- 503A Facility, Inventive Infusion Solutions, LP, San Antonio, TX- 503A Facility, In Your Atmosphere Holdings LLC (dba Highland Pharmacy) Santa Fe, NM- 503A Facility, Ionia Pharmacy, Tustin, CA- 503A Facility, Irmat Pharmacy (see Park Irmat Corp.) New York, NY- 503A Facility, Isomeric Pharmacy Solutions, LLC, Salt Lake City, UT- 503A Facility - Out of business, Isorx, Corp., Richmond, CA- 503A Facility, IV Solutions of Lubbock(see Maxor National Pharmacy Services Corporation), Lubbock, TX- 503A Facility, I.V. Home Infusion Therapy Pharmacy. Lead Counsel? Release of Transcript Restriction set for 10/4/2021. Lead Counsel? Leagle.com reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions. This Court dismissed the ERISA claims. Electronic ROA due on 09/30/2021. [21-30534] (LBM) [Entered: 09/13/2021 04:19 PM], INITIAL CASE CHECK by Attorney Advisor complete. Advanced Infusion Solutions insights Based on 16 survey responses What people like Ability to learn new things Ability to meet personal goals Areas for improvement Sense of belonging Support from manager Trust in colleagues Interesting niche business with big focus on quality. (Entered: 03/04/2021), Docket(#7) ORDER for Extension of Time to Respond to Complaint #1 , ( Response due by 3/4/2021) Signed by District Judge Denise Page Hood. See Order [61]. 2:19-CV-11980 | 2019-07-02, U.S. District Courts | Contract | The Counterclaim alleges that each time AIS improperly billed using the S9328 code it made a representation that it had performed those services when it had not. But they disagree as to whether AIS breached it. Access this case on the Michigan Eastern District Court's Electronic Court Filings (ECF) System. 1 star. Univ. Ct. App. Owned by: Advanced Infusion Solutions Acquisition, LLC Serial Number: 87399535. Is this your business? 2012) (internal quotations omitted)). The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Specialty, Ltd. Austin, TX- 503A Facility - Out of business, J & F International Inc.(dba Alexandria Medical Arts Pharmacy & Compounding Laboratory), Alexandria, VA- 503A Facility, Jack P. Herick Inc. (dba Glades Drugs), Pahokee, FL- 503A Facility, Jacobs Pills Inc. (dba The Healthy Choice Apothecary), Elmsford, NY- 503A Facility, Jajco Inc. (dba Anchor Drugs Pharmacy), South San Francisco, CA- 503A Facility, JCB Laboratories, LLC, Wichita, KS- 503A Facility - Out of business, JD & SN Inc. (dba Moses Lake Professional Pharmacy), Moses Lake, WA- 503A Facility, Jeffreys Drug Store, Canonsburg, PA- 503A Facility, Joe Wise Pharmacy, Inc., (dba Wise Pharmacy), Littleton, CO- 503A Facility - Out of business, John Hollis Pharmacy, (see John W. Hollis, Inc.), Nashville, TN- 503A Facility, John W. Hollis, Inc.(dba John Hollis Pharmacy), Nashville, TN- 503A Facility, John L. McClellan Memorial Veterans Hospital, Little Rock, AR- 503A Facility, John's Pharmacy, Inc.,(dba The Sullivan Pharmacy), Sullivan, IL- 503A Facility, Johns Pharmacy LLLP, Cape Girardeau, MO- 503A Facility, Johnson Compounding and Wellness,(see Merissa Corp.), Waltham, MA- 503A Facility, Johnson Memorial Cancer Center, Enfield, CT- 503A Facility, Jones Drug Company, Inc., (dba Reed's Compounding Pharmacy), Tucson, AZ- 503A Facility, Jubilant DraxImage Radiopharmacies, Inc., (dba Triad Isotopes, Inc.), Kansas City, MO- 503A Facility, Jubilant HollisterStier, LLC, Spokane, WA- 503A Facility - De-registered as an Outsourcing Facility, Jungle Jim's Pharmacy, Fairfield, OH- 503A Facility, J.W. Jul. Transcript order due on 09/23/2021, for Appellant Randy Denning. Date of service: 10/19/2021 via email - Attorney for Appellants: Burns, Camel, Richardson; Attorney for Appellees: Matini, Patron, Spencer-Davis, Werner [21-30534] (Roberta Louise Burns ) [Entered: 10/19/2021 02:16 PM], APPEARANCE FORM for the court's review. They contend AIS merely delivered the pharmaceutical component to other providers who administered the drug and managed the patient's care. Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. Pasar al contenido principal LinkedIn. Langham v. Behnen,39 So.3d 970, 976 (Miss. If you are not a monthly . 34. These allegations are sufficient to plausibly state a claim for breach of good faith and fair dealing. [21-30534] (DDL) [Entered: 09/17/2021 02:01 PM], ELECTRONIC RECORD ON APPEAL REQUESTED from District Court for 2:21-CV-774. 25. 13. Human Drug Compounding, Recalls, Market Withdrawals and Safety Alerts, Compounding Quality Center of Excellence On-demand Training, Compounding Oversight and Compliance Actions, Compounding: Inspections, Recalls, and other Actions, Consumer and Health Care Professional Information, Guidance, Compliance, & Regulatory Information, 2014 - 2015 Compounding: Inspections, Recalls, and other Actions, Referral Letter to the California State Board of Pharmacy Issued 07/06/2020, Referral Letter to the Florida State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Virginia State Board of Pharmacy dated 01/29/2020, Referral Letter to the Missouri Board of Pharmacy dated 06/16/2022, Referral Letter to the Nevada State Board of Pharmacy dated 07/13/2022, Referral Letter to the Virginia State Board of Pharmacy Issued 06/08/2017, Referral Letter to the New York State Board of Pharmacy Issued 05/08/2017, Referral Letter to the Delaware State Board of Pharmacy Issued 04/28/2017, Referral Letter to Florida State Board of Pharmacy Issued 10/09/2015, Referral Letter to the New York State Board of Pharmacy Issued 03/22/2017, Referral Letter to Florida Board of Pharmacy Issued 02/21/2014, Referral Letter to State of New Hampshire Board of Pharmacy Issued 06/07/2016, Referral Letter to the Kansas State Board of Pharmacy Issued 03/06/2019, Referral Letter to the North Carolina State Board of Pharmacy Issued 08/19/2019, Referral Letter to the Arizona State Board of Pharmacy Issued 04/09/2020, Referral to the Rhode Island State Board of Pharmacy Issued 07/25/2017, Referral Letter to the California State Board of Pharmacy Issued 08/31/2017, Referral to the New York State Board of Pharmacy Issued 11/16/2017, Referral Letter to the Mississippi Board of Pharmacy Issued 08/02/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 10/29/2019, Referral Letter to the Ohio State Board of Pharmacy Issued 05/01/2019, Referral Letter to the Florida Board of Pharmacy Issued on 01/31/17, Referral Letter to the Georgia State Board of Pharmacy Issued 11/18/2019, Referral to the Connecticut State Board of Pharmacy Issued 07/12/2017, Referral Letter to the Louisiana Board of Pharmacy Issued 11/03/2022, Referral Letter to the Michigan Board of Pharmacy Issued 03/22/2017, Referral Letter to the Ohio State Board of Pharmacy Issued 08/09/17, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 01/17/17, Referral Letter to the California State Board of Pharmacy Issued 07/20/2020, FDA Alerts Health Care Professionals and Patients not to Use Sterile Drug Products from Chen Shwezin Inc., dba Park Compounding Pharmacy, Referral Letter to the Michigan Board of Pharmacy Issued 09/09/16, Referral Letter to the Ohio Board of Pharmacy Issued 05/30/2014, Referral Letter to the Mississippi State Board of Pharmacy Issued 11/05/2019 Shutdown Letter, Referral Letter to the Mississippi Board of Pharmacy Issued 06/27/2019, Referral Letter to the Georgia State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Indiana State Board of Pharmacy Issued 10/02/2019, Referral Letter to the Arkansas State Board of Pharmacy Issued 10/28/2020, Referral Letter to the California State Board of Pharmacy Issued 12/14/2015, Leader of $17 Million Health Insurance Fraud Scheme Ordered to Prison, Referral Letter to the Texas State Board of Pharmacy Issued 05/18/2020, FDA Requested Recall Letter Issued 09/09/2014, FDA Requested Recall Letter Issued 07/26/2013, Referral Letter to New Jersey State Board of Pharmacy Issued 02/21/2014, Referral Letter to the Georgia State Board of Pharmacy Issued 05/19/2020, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/29/2019, FDA warns patients and health care professionals not to use sterile products from North American Custom Laboratories LLC, dba FarmaKeio Superior Custom Compounding, Referral Letter to Missouri Board of Pharmacy Issued 02/26/2014, Referral Letter to the Alaska State Board of Pharmacy dated 02/18/2020, Referral Letter to the Alaska State Board of Pharmacy dated 02/06/2020, Referral Letter to the Tennessee Board of Pharmacy Issued 02/08/2017, FDAs Investigation into Guardians Compounded Triamcinolone-Moxifloxacin Drug Product, FDA Alerts Health Care Professionals of Adverse Events Associated with Guardians Compounded Triamcinolone and Moxifloxacin Product for Intravitreal Injection, Corrected (No Redactions) 483 Issued 10/21/2016, Referral Letter to the Texas State Board of Pharmacy Issued 03/24/2021, Referral to the California State Board of Pharmacy Issued 09/26/2017, Referral Letter to the Michigan State Department of Licensing and Regulatory Affairs (LARA) Issued 05/21/2015, Referral Letter to the Florida State Board of Pharmacy Issued 01/23/2017, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 03/27/2014, Referral Letter to the Texas State Board of Pharmacy Issued 05/05/2016, Referral Letter to the Maryland State Board of Pharmacy Issued 08/23/2019, A Case of Hemorrhagic Occlusive Retinal Vasculitis (HORV) Following Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin Formulation, FDA Investigates Two Serious Adverse Events Associated with ImprimisRxs Compounded Curcumin Emulsion Product for Injection, Investigation Memo and Attachments, 08/16/2011, Referral Letter to the Minnesota State Board of Pharmacy Issued 07/01/2019, Referral to the South Carolina State Board of Pharmacy Issued 09/13/2017, Referral Letter to the Ohio Board of Pharmacy Issued 03/28/2019, Referral Letter to the ColoradoBoard of Pharmacy Issued 12/23/2020, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 10/03/2019, Referral Letter to the New Mexico State Board of Pharmacy Issued 08/22/2017, Maxor National Pharmacy Services Corporation, Referral Letter to the Texas Board of Pharmacy Issued 03/18/2014, Alexandria Medical Arts Pharmacy & Compounding Laboratory, Referral Letter to the Florida Board of Pharmacy Issued 04/21/2017, FDA announces Glades Drugs nationwide voluntary recall of Compounded Multivitamins containing High Amounts of Vitamin D3 (Cholecalciferol), Referral Letter to the California State Board of Pharmacy Issued 12/06/2019, Referral Letter to the Missouri State Board of Pharmacy Issued 01/10/2017, Referral Letter to the Missouri State Board of Pharmacy Issued 03/10/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 08/11/2015, Referral Letter to the Illinois State Board of Pharmacy Issued 09/11/2019, Referral Letter to the New York State Board of Pharmacy Issued 11/15/2019, Referral Letter to the California State Board of Pharmacy Issued 11/22/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 07/11/2019, Referral Letter to Oklahoma State Board of Pharmacy Issued 02/25/2014, Referral Letter to the New York State Board of Pharmacy Issued 06/06/2019, Referral Letter to the Massachusetts Department of Public Health Issued 10/14/2015, Referral to the New York State Education Department, Office of the Professions, Pharmacy Issued 07/07/2017, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/10/2019, Referral Letter to the Oklahoma State Board of Pharmacy Issued 10/2/2020, Referral Letter to the Missouri Board of Pharmacy Issued 02/18/2015, FDA Requested Recall Letter Issued 05/03/2016, Referral Letter to the South Carolina State Board of Pharmacy Issued 05/21/2015, Referral to the Texas State Board of Pharmacy Issued 07/28/2017, State Referral Letter to the Nevada State Board of Pharmacy issued 12/06/2017, Referral Letter to Massachusetts Board of Registration in Pharmacy Issued 01/20/2016, Barclay Luke & Pillai Specialty Pharmacy PLLC, Referral Letter to the Arizona State Board of Pharmacy Issued 05/23/2017, Referral Letter to the Michigan State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Tennessee Board of Pharmacy Issued 04/05/2017, Referral Letter to the Wisconsin State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 05/09/2016, Unlicensed Pharmacy Technician Sentenced for Working at New England Compounding Center, Owner and Four Former Employees of New England Compounding Center Convicted Following Trial, Unlicensed Pharmacy Technician Pleads Guilty to Working at New England Compounding Center, Compounding Pharmacy Owner Sentenced to Five Years in Prison for $10.5 Million Health Care Fraud, Multistate outbreak of fungal meningitis and other infections, Referral to the Massachusetts State Board of Registration in Pharmacy Issued 09/26/2017, Referral Letter to New Hampshire State Board of Pharmacy Issued 04/29/2015, Referral Letter to the Kentucky State Board of Pharmacy Issued 03/04/2020, Referral to the Kansas State Board of Pharmacy Issued 06/28/2017, Referral Letter to the Illinois State Board of Pharmacy Issued 07/01/2020, Referral Letter to the Illinois State Board of Pharmacy Issued 10/31/2019, Referral Letter to the California State Board of Pharmacy Issued 07/08/2020, Referral Letter to Florida State Board of Pharmacy Issued 03/10/2021, Amended 483 and Cover Letter Issued 04/09/2013 and 483 Issued 03/29/2013, Referral Letter to the Tennessee State Board of Pharmacy Issued 09/13/2019, Referral Letter to the Florida State Board of Pharmacy Issued 04/22/2019, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 05/05/2017, Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients, Referral Letter to the Texas State Board of Pharmacy Issued 03/12/2019, Referral Letter to the Kansas State Board of Pharmacy Issued 03/29/2017, Pharmacy Creations Issues Voluntary Recall of Four Product Lots With Limited Distribution in Florida, New Jersey, New York, and Puerto Rico Due to Potential Non-Sterility (09/04/2014), Referral Letter to the Indiana State Board of Pharmacy Issued 03/06/2017, Pharmacy Owner and Director of Compliance Charged with Defrauding United States and Distributing Adulterated Drugs, Referral Letter to the New Jersey State Board of Pharmacy Issued 07/29/2019, Referral to the Oklahoma State Board of Pharmacy Issued 07/28/2017, Referral Letter to the Georgia State Board of Pharmacy Issued 08/14/2020, Referral Letter to New York State Board of Pharmacy Issued 11/07/2016, Referral Letter to the New Jersey State Board of Pharmacy Issued 01/11/2017, Referral Letter to Michigan Board of Pharmacy Issued 02/25/2014, Referral Letter to the California State Board of Pharmacy Issued 04/05/2017, Referral Letter to the Colorado State Board of Pharmacy Issued 04/14/2020, Referral Letter to the FloridaBoard of Pharmacy Issued 07/27/2022, Referral Letter to the Ohio State Board of Pharmacy Issued 09/12/2019, Referral to the New York State Board of Pharmacy Issued 06/15/2017.